JP2021073453A5 - - Google Patents

Download PDF

Info

Publication number
JP2021073453A5
JP2021073453A5 JP2021003537A JP2021003537A JP2021073453A5 JP 2021073453 A5 JP2021073453 A5 JP 2021073453A5 JP 2021003537 A JP2021003537 A JP 2021003537A JP 2021003537 A JP2021003537 A JP 2021003537A JP 2021073453 A5 JP2021073453 A5 JP 2021073453A5
Authority
JP
Japan
Prior art keywords
salt
proteins
disease
protein
protein profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021003537A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021073453A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021073453A publication Critical patent/JP2021073453A/ja
Publication of JP2021073453A5 publication Critical patent/JP2021073453A5/ja
Priority to JP2023034247A priority Critical patent/JP2023078210A/ja
Pending legal-status Critical Current

Links

JP2021003537A 2015-10-07 2021-01-13 血液の調製及びプロファイリング Pending JP2021073453A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023034247A JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2015904075A AU2015904075A0 (en) 2015-10-07 Blood preparation and profiling
AU2015904075 2015-10-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018537693A Division JP6824994B2 (ja) 2015-10-07 2016-10-06 血液の調製及びプロファイリング

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023034247A Division JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Publications (2)

Publication Number Publication Date
JP2021073453A JP2021073453A (ja) 2021-05-13
JP2021073453A5 true JP2021073453A5 (cg-RX-API-DMAC7.html) 2021-06-24

Family

ID=58487130

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018537693A Active JP6824994B2 (ja) 2015-10-07 2016-10-06 血液の調製及びプロファイリング
JP2021003537A Pending JP2021073453A (ja) 2015-10-07 2021-01-13 血液の調製及びプロファイリング
JP2023034247A Pending JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018537693A Active JP6824994B2 (ja) 2015-10-07 2016-10-06 血液の調製及びプロファイリング

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023034247A Pending JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Country Status (10)

Country Link
US (2) US11243218B2 (cg-RX-API-DMAC7.html)
EP (2) EP3359962B1 (cg-RX-API-DMAC7.html)
JP (3) JP6824994B2 (cg-RX-API-DMAC7.html)
KR (1) KR102632490B1 (cg-RX-API-DMAC7.html)
CN (2) CN114019171A (cg-RX-API-DMAC7.html)
AU (1) AU2016334875B2 (cg-RX-API-DMAC7.html)
CA (1) CA3001154C (cg-RX-API-DMAC7.html)
HK (1) HK1258470A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201802754XA (cg-RX-API-DMAC7.html)
WO (1) WO2017059477A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016374643B2 (en) * 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
US20240352423A1 (en) * 2021-03-10 2024-10-24 Terasaki Institute For Biomedical Innovation Methods and systems of producing products such as animal derived products
CN114081899A (zh) * 2021-11-02 2022-02-25 四川大学华西医院 一种富白细胞富血小板血浆的制备方法
JP7772425B2 (ja) 2022-03-23 2025-11-18 株式会社ミルテル ニコチンアミドアデニンジヌクレオチド(nad+)又はニコチンアミドモノヌクレオチド(nmn)を定量する方法、並びにその方法を実施するためのキット及び濾紙
WO2024010763A1 (en) * 2022-07-07 2024-01-11 Russell Biotech, Inc. Preparation of platelet free mononuclear cells

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931276A (en) 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
WO1992005801A1 (en) 1990-10-04 1992-04-16 University Of Virginia Alumni Patents Foundation Primate erythrocyte bound monoclonal antibody heteropolymers
PT706799E (pt) * 1994-09-16 2002-05-31 Merck Patent Gmbh Imunoconjugados ii
US5763280A (en) * 1997-01-21 1998-06-09 Coulter International Corp. Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
FR2778851B1 (fr) 1998-05-19 2002-07-26 Aetsrn Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
US8431117B2 (en) 1999-08-30 2013-04-30 David S Terman Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
EP1355656A2 (en) 2000-07-24 2003-10-29 Gendel Limited Red blood cell as vehicle for agent-membrane translocation sequence conjugate
ES2498369T3 (es) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Un marcador para medir cirrosis hepática
US7501286B2 (en) 2002-08-14 2009-03-10 President And Fellows Of Harvard College Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry
US7276382B2 (en) * 2003-10-02 2007-10-02 Noboru Horiguchi Blood testing method
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US7378054B2 (en) 2004-04-16 2008-05-27 Savvipharm Inc Specimen collecting, processing and analytical assembly
US7803523B2 (en) * 2004-08-27 2010-09-28 University Health Network Whole blood preparation for cytometric analysis of cell signaling pathways
US20060166223A1 (en) * 2005-01-26 2006-07-27 Reed Michael W DNA purification and analysis on nanoengineered surfaces
WO2006123253A2 (en) 2005-03-29 2006-11-23 Inverness Medical Switzerland Gmbh Device and method of monitoring a patient
US20100184049A1 (en) 2007-04-27 2010-07-22 Steve Goodison Glycoprotein Profiling of Bladder Cancer
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
US8530182B2 (en) 2007-12-05 2013-09-10 Centers For Disease Control And Prevention Viral protein quantification process and vaccine quality control therewith
CN102037355A (zh) 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
US20110086424A1 (en) 2008-05-06 2011-04-14 Advanced Cell Technology, Inc. Methods for producing enucleated erythroid cells derived from pluripotent stem cells
WO2010147621A1 (en) 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells
SG177407A1 (en) * 2009-06-30 2012-02-28 Kaneka Corp Blood component separation system and separation material
CA2769889A1 (en) * 2009-08-13 2011-02-17 Basf Se Means and methods for diagnosing thyroid disorders
WO2011091154A2 (en) 2010-01-21 2011-07-28 The Regents Of The University Of California Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
AU2011212477A1 (en) 2010-02-08 2012-08-30 Piramal Imaging Sa F18-tyrosine derivatives for imaging bone metastases
WO2011127056A2 (en) 2010-04-05 2011-10-13 The Uab Research Foundation Biomarkers for assessing exposure to ionizing radiation and absorbed dose
US20150111238A1 (en) 2011-05-31 2015-04-23 Singapore Health Services Pte. Ltd. Method for detecting disease biomarkers
GB201116767D0 (en) 2011-09-28 2011-11-09 St George S Hospital Medical School Treatment for mitrochondrial neurogastrointestinal encephalomyopathy
US20150086521A1 (en) 2012-03-21 2015-03-26 Erytech Pharma Medicament for the Treatment of Acute Myeloid Leukemia (AML)
HU230341B1 (hu) * 2012-04-20 2016-02-29 Advancell Diagnosztika Kft. A vörösvérsejt-membrán kvantitatív biomarkerei
WO2014011901A2 (en) 2012-07-11 2014-01-16 Sangamo Biosciences, Inc. Methods and compositions for delivery of biologics
CN105228596B (zh) 2013-05-10 2018-08-24 爱瑞德勒股份有限公司 用于制备载有一种或多种制药学感兴趣物质的红细胞的方法和由此得到的红细胞
JP6383920B2 (ja) * 2013-09-11 2018-09-05 有限会社ピコデバイス パーキンソン病の判定基準とする方法
KR20160073382A (ko) * 2013-10-04 2016-06-24 셀 아이디어스 피티와이 엘티디 세포 치료를 위한 바이오마커들
KR101845588B1 (ko) 2014-04-07 2018-04-05 한양대학교 산학협력단 적혈구계 세포의 인 비트로 확장
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
AU2016374643B2 (en) 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング

Similar Documents

Publication Publication Date Title
Guo et al. Cytokine signature associated with disease severity in COVID-19
Boucly et al. Cytokines as prognostic biomarkers in pulmonary arterial hypertension
Maruoka et al. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
Morimoto et al. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis
Zhang et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis
JP2018530766A5 (cg-RX-API-DMAC7.html)
Khoury et al. Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder
Hayashi et al. Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
US20210255183A1 (en) Method for predicting therapeutic effect of biological preparation on rheumatoid arthritis
Thuma et al. Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia
Xu et al. Simple evaluation of clinical situation and subtypes of pediatric hemophagocytic lymphohistiocytosis by cytokine patterns
Doerflinger et al. Procalcitonin and interleukin-10 may assist in early prediction of bacteraemia in children with cancer and febrile neutropenia
AU2016334875B2 (en) Blood preparation and profiling
US12560614B2 (en) Method for diagnosing and treating fibromyalgia
Kleiner et al. Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17
Gibellini et al. Plasma cytokine atlas reveals the importance of TH2 polarization and interferons in predicting COVID-19 severity and survival
Hocum Stone et al. Serum cytokine profiles in healthy nonhuman primates are blunted by sedation and demonstrate sexual dimorphism as detected by a validated multiplex immunoassay
Cheng et al. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases
Arsentieva et al. Predictive value of specific cytokines for lethal COVID-19 outcome
Harasawa et al. Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma
Lereim et al. Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival
Imaizumi et al. Involvement of retinoic acid-inducible gene-I in the IFN-γ/STAT1 signalling pathway in BEAS-2B cells
Di et al. Role of chemotaxis of Vδ2 T cells to the synovium in the pathogenesis of acute gouty arthritis
Stelmasiak et al. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
MacLaughlin et al. 100% oxygen mobilizes stem cells and up-regulates MIF and APRIL in humans: a new point on the hormetic dose curve